Paul De Boissieu

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Health-related quality of life reporting in randomized controlled trials of chimeric antigen receptor T-cell therapy: A systematic review of dedicated publications.

Health-related quality of life reporting in randomized controlled trials of chimeric antigen receptor T-cell therapy: A systematic review of dedicated publications.

Journal: British journal of haematology

Published: March 31, 2026

Improving the Reporting of Long-Term Effects in the IMpower010 Trial.

Improving the Reporting of Long-Term Effects in the IMpower010 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 10, 2025

Considerations for results of the patient-reported outcome analyses of the TALAPRO-2 trial.

Considerations for results of the patient-reported outcome analyses of the TALAPRO-2 trial.

Journal: The Lancet. Oncology

Published: April 11, 2025

Health technology assessment in Europe: A comparison of organizations and introduction to the European regulation.

Health technology assessment in Europe: A comparison of organizations and introduction to the European regulation.

Journal: Presse medicale (Paris, France : 1983)

Published: December 13, 2024

Misleading Reporting of a Negative Randomized Clinical Trial May Affect Clinical Practice.

Misleading Reporting of a Negative Randomized Clinical Trial May Affect Clinical Practice.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 09, 2024

Omitting study limitations might have implications for the patients.

Omitting study limitations might have implications for the patients.

Journal: The Lancet. Oncology

Published: September 30, 2024

Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule.

Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 24, 2024

Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS).

Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 26, 2024

The Prognostic Value of Olfactory Dysfunction in Patients with COVID-19: The COVIDORA Study.

The Prognostic Value of Olfactory Dysfunction in Patients with COVID-19: The COVIDORA Study.

Journal: Life (Basel, Switzerland)

Published: January 29, 2024

Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study.

Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study.

Journal: Journal of the International AIDS Society

Published: May 11, 2023

Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study.

Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study.

Journal: Journal of clinical medicine

Published: July 25, 2022

Analysis of whole-body MRI artifacts in a pediatric population with a special emphasis on the effect of hands position.

Analysis of whole-body MRI artifacts in a pediatric population with a special emphasis on the effect of hands position.

Journal: Diagnostic and interventional imaging

Published: June 17, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026